Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Riedl

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Radiology|April 8, 2020
CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human ImagingGary A Ulaner, Nicholas B Sobol, Joseph A O'Donoghue, et al.
Radiology|June 10, 2020
Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted <sup>89</sup>Zr-Pertuzumab PET/CTGary A Ulaner, Jorge A Carrasquillo, Christopher C Riedl, et al.
JAMA Network Open|October 9, 2020
Regional Lymph Node Involvement Among Patients With De Novo Metastatic Breast CancerAlmir Bitencourt, Carolina Rossi Saccarelli, Elizabeth A Morris, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2017
Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysisXuan-Anh Phi, Nehmat Houssami, Maartje J Hooning, et al.
British Journal of Cancer|February 25, 2016
Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysisXuan-Anh Phi, Sepideh Saadatmand, Geertruida H De Bock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2014
Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysisXuan-Anh Phi, Nehmat Houssami, Inge-Marie Obdeijn, et al.
Neuro-Oncology Advances|January 4, 2021
Preclinical and first-in-human-brain-cancer applications of [<sup>18</sup>F]poly (ADP-ribose) polymerase inhibitor PET/MRRobert J Young, Paula Demétrio De Souza França, Giacomo Pirovano, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Radiology|April 8, 2020
CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human ImagingGary A Ulaner, Nicholas B Sobol, Joseph A O'Donoghue, et al.
Radiology|June 10, 2020
Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted <sup>89</sup>Zr-Pertuzumab PET/CTGary A Ulaner, Jorge A Carrasquillo, Christopher C Riedl, et al.
JAMA Network Open|October 9, 2020
Regional Lymph Node Involvement Among Patients With De Novo Metastatic Breast CancerAlmir Bitencourt, Carolina Rossi Saccarelli, Elizabeth A Morris, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2017
Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysisXuan-Anh Phi, Nehmat Houssami, Maartje J Hooning, et al.
British Journal of Cancer|February 25, 2016
Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysisXuan-Anh Phi, Sepideh Saadatmand, Geertruida H De Bock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2014
Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysisXuan-Anh Phi, Nehmat Houssami, Inge-Marie Obdeijn, et al.
Neuro-Oncology Advances|January 4, 2021
Preclinical and first-in-human-brain-cancer applications of [<sup>18</sup>F]poly (ADP-ribose) polymerase inhibitor PET/MRRobert J Young, Paula Demétrio De Souza França, Giacomo Pirovano, et al.
Pageof 5